---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-110266"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2026-10-16T20:30:14+00:00"
generated_at: "2026-10-16T20:31:07.916353+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Envoy Medical holders approve reverse split of 1-for-5 to 1-for-25 by Dec. 31, 2026

## Summary
- At the Oct. 12, 2026 Special Meeting, stockholders approved amending the charter to let the board effect one or more reverse splits of Class A common stock at ratios from 1-for-5 to 1-for-25.
- The reverse split authority expires on or before December 31, 2026, and any split is at the discretion of the Board of Directors.
- Reverse Stock Split Proposal tallied 44,012,206 votes for, 50,668 against and 1,872 abstained.
- The Adjournment Proposal passed 43,642,799 for, 406,221 against and 15,726 abstained; the adjournment authority was not used.
- CEO Brent T. Lucas signed the report Oct. 16, 2026; Class A common stock trades as COCH and warrants as COCHW on Nasdaq.

## SEC filing metadata
- accession: 0001213900-26-110266
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2026-10-16T20:30:14+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000121390026110266/0001213900-26-110266-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000121390026110266/ea0308812-8k_envoy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-110266
- JSON: https://secwatch.observer/filing/0001213900-26-110266.json
- Plain text: https://secwatch.observer/filing/0001213900-26-110266.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.